Analysing Modafinil Analogues: Why GC Misleads
Modafinil, adrafinil, CRL-40,940 and CRL-40,941 degrade in the GC injector. What the literature says about method selection for this family.
A compound that survives your sample preparation can still be destroyed by your instrument. For the modafinil family the failure mode is documented, reproducible and easy to miss: the sulfoxide decomposes in the hot gas-chromatography injector and produces a degradation product that is not the analyte. This note sets out what the published analytical literature says about method selection for these compounds. Written for laboratory audiences; compounds referenced are supplied for research use only (RUO).
What happens in the GC injector?
Dowling and colleagues examined the thermal behaviour of modafinil, modafinic acid, adrafinil, CRL-40,940 and CRL-40,941 under gas-chromatographic conditions and reported that these compounds degrade in the injector, forming 1,1,2,2-tetraphenylethane and, for the fluorinated pair, its tetrafluoro analogue (Dowling et al., 2017). The paper’s title — “Outsmarted by nootropics?” — is a fair description of the analytical trap.
The mechanism is structural rather than exotic. All five compounds are benzhydryl sulfoxides or their fluorinated equivalents. Heat the sulfoxide in an injector and the C–S bonds do not survive intact; what reaches the column is a symmetric hydrocarbon derived from the two aryl rings. Crucially, that product is common to several members of the family. Modafinil and adrafinil both give tetraphenylethane; flmodafinil and fladrafinil both give the tetrafluoro analogue.
A degradation product shared by two compounds cannot distinguish between them. If the instrument makes the analytes converge, no amount of downstream interpretation pulls them back apart.
Why does that matter beyond a single bad peak?
Three consequences follow, and they compound.
Identity collapses across the pair. If CRL-40,940 and CRL-40,941 both degrade to the same tetrafluoro product, a GC method keyed to that product cannot tell you which you have. Given that the two are already routinely interchanged in supplier listings, an analytical route that erases the distinction removes the last place the error could have been caught.
Quantitation becomes conditional on the injector. Degradation extent depends on injector temperature, liner condition and residence time — parameters that vary between instruments and drift within one. A response that is part analyte and part decomposition product is not a stable basis for a purity figure.
Absence is not evidence. A laboratory screening by GC and finding no parent compound may be looking at a sample where the parent was consumed by the method. For a compound family now named under class S6 of the 2026 Prohibited List, a false negative has consequences beyond the bench.
What does the literature use instead?
Liquid chromatography with mass spectrometry, consistently, in every recent study on these compounds.
| Study | Matrix | Technique | Analytes |
|---|---|---|---|
| Krug et al., 2026 | Urine, dried blood spots | LC-HRMS | Flmodafinil, fladrafinil and metabolites; LOD 0.2–4 ng/mL |
| Bakota & Nandrea, 2025 | Products marketed as supplements | LC-HRMS, validated | Modafinil, adrafinil, CRL-40,940, CRL-40,941, N-methyl-4,4-difluoromodafinil |
| Ameline et al., 2020 | Human hair | LC-MS/MS | Adrafinil and its metabolite modafinil |
| Dowling et al., 2017 | Standards | GC (degradation study) | The family; documents the injector artefact itself |
Analytical approaches in the published literature on the eugeroic series. The only GC study in the set is the one characterising why GC fails.
3 of 4 published studies on this family use liquid chromatography; the fourth exists to document the gas-chromatography artefact.
That convergence is itself the recommendation. Bakota and Nandrea’s method is the most directly reusable for material characterisation, because it was validated to quantitate four analogues alongside the parent in real commercial products rather than in clean standards. Krug and colleagues’ work is the reference for biological matrices and gives the metabolite set — flmodafinil acid and flmodafinil sulfone — that confirmation work needs.
What should a method look like in practice?
Four points, in the order they bite. Select LC over GC for any work where parent-compound identity matters, which for this family is all of it. Resolve by accurate mass, where 309.33 against 325.3 g/mol separates the fluorinated pair cleanly. Include the metabolites when working in biological matrices, and remember that the prodrug relationship means fladrafinil and flmodafinil converge on the same metabolite profile, so the parent is the discriminating measurement. And characterise the finished form, not only the bulk: an encapsulated product introduces excipients and a filling step that a certificate on the raw powder does not cover.
That last point is why our own flmodafinil listing shows its purity field as pending rather than carrying a figure inherited from elsewhere. For the compound comparison behind this method discussion, see flmodafinil vs adrafinil. Related reading on format and handling: capsule versus vial for research compounds.
All compounds referenced are supplied strictly for research use only and are not drugs, supplements, foods, cosmetics or articles for human or veterinary use.
References
- Dowling G, Kavanagh PV, Talbot B, O’Brien J, Hessman G, McLaughlin G, Twamley B, Brandt SD. Outsmarted by nootropics? An investigation into the thermal degradation of modafinil, modafinic acid, adrafinil, CRL-40,940 and CRL-40,941 in the GC injector. Drug Testing and Analysis. 2017;9(3):518–528. PMID 27928893. doi:10.1002/dta.2142
- Krug O, Guddat S, Görgens C, Walpurgis K, Toma F, Thomas A, Thevis M. Investigations into the metabolism and elimination of flmodafinil and fladrafinil for sports drug testing purposes. Drug Testing and Analysis. 2026;18(8):1076–1087. PMID 42210629. doi:10.1002/dta.70100
- Bakota EL, Nandrea JM. Development and validation of an analytical method to identify and quantitate novel modafinil analogs in products marketed as dietary supplements. Journal of Dietary Supplements. 2025;22(2):329–344. PMID 39466147. doi:10.1080/19390211.2024.2417673
- Ameline A, Gheddar L, Raul JS, Kintz P. Identification of adrafinil and its main metabolite modafinil in human hair. Self-administration study and interpretation of an authentic case. Forensic Sciences Research. 2020;5(4):322–326. PMID 33457050. doi:10.1080/20961790.2019.1704482
- National Center for Biotechnology Information. PubChem Compound Summary, CID 13271852, Flmodafinil. pubchem.ncbi.nlm.nih.gov (accessed 22 September 2026)
Why is gas chromatography a problem for these compounds?
Because they degrade in the injector. Dowling and colleagues reported that modafinil, modafinic acid, adrafinil, CRL-40,940 and CRL-40,941 decompose thermally under GC conditions, forming 1,1,2,2-tetraphenylethane and, for the fluorinated pair, its tetrafluoro analogue. What reaches the column is not the analyte.
Does the degradation affect identification or only quantitation?
Both, and identification more seriously. The degradation product is shared across compounds: modafinil and adrafinil both yield tetraphenylethane, while flmodafinil and fladrafinil both yield the tetrafluoro analogue. A method keyed to that product cannot distinguish between members of each pair.
What technique does the published literature use instead?
Liquid chromatography with mass spectrometry, consistently. Recent studies on this family use LC-HRMS for urine and dried blood spots, validated LC-HRMS for marketed products, and LC-MS/MS for hair. The only gas-chromatography study in the set is the one documenting why GC fails.
Can a negative GC screen be trusted?
Not without qualification. If the parent compound is consumed in the injector, a laboratory may record an absence that reflects the method rather than the sample. For compounds named under class S6 of the 2026 Prohibited List, that false negative has consequences beyond the bench.
Does a certificate on the bulk powder cover an encapsulated product?
No. An encapsulated form introduces excipients and a filling step that testing on the raw material does not address. Identity, content per unit and uniformity in the finished form are separate measurements.